MONITORING OF CLINICAL TRIALS AND STUDIES - NIAID
Release Date: July 8, 2002
National Institute of Allergy and Infectious Diseases (NIAID)
Effective Date of New Monitoring Policy: October 1, 2002
Notice AI-00-003 in the February 25, 2000 NIH Guide announced the
availability of "NIAID POLICY ON MONITORING GRANTS SUPPORTING CLINICAL TRIALS
AND STUDIES" (http://grants.nih.gov/grants/guide/notice-files/NOT-AI-00-003.html).
Standard NIAID Terms and Conditions of Award for clinical studies
and trials were promulgated. These terms and conditions of award will remain
in effect until September 30, 2002 will be found at:
Since that time, there have been many changes in policy concerning the
appropriate conduct of clinical research.
As a result, NIAID is updating its policy and announcing the availability of
updated "Clinical Terms of Award" that will become effective on October 1,
2002. Awardees will be required to comply with these updated Clinical Terms
of Award. The terms will be incorporated in their Notices of Grant Award or
contracts. These terms require that all clinical trials and studies
supported by NIAID be monitored commensurate with the degree of potential
risk to study subjects and complexity of the study.
The details of the new policy can be found at the following location:
http://www.niaid.nih.gov/ncn/pdf/clinterm.pdf. Guidance information
concerning the new policy will be available at:
Inquiries about a specific grant, cooperative agreement, or contract should
be directed to the NIAID Program Officer for that award. For all applications
and grants, the Program Officer is identified in the upper left corner of the
first page of the summary statement.
Inquires about potential applications or proposals should be directed to the
appropriate NIAID staff member (See http://www.niaid.nih.gov/ncn/staff/p-and-s.htm).
General inquiries related to this notice may be directed to:
Division of Extramural Activities, NIAID
Room 2142, 6700-B Rockledge Drive MSC 7610
Bethesda, MD 20892-7610
Telephone: (301) 496-7291
FAX: (301) 402-0369
E-mail: email@example.com or firstname.lastname@example.org
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices